Clinical Oncology: Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Lindsey Addington Author

Subjects of specialization
Metastatic adrenocortical carcinoma,Immunotherapy,Pembrolizumab

Affiliation
Diagnostic Radiology, Community Hospital Cancer Center, 1440 East County Line Road Indianapolis

Biography

Dr. Addington works in Indianapolis, IN and 1 other location and specializes in Medical Oncology and Nurse Practitioner. Ms. Addington is affiliated with Franciscan Saint Francis Health, Community Hospital East, Community Health Network South Campus, Community Hospital North and Community Hospital North


Publications

Case Report Open Access

Impressive Response to Immunotherapy in a Patient with Metastatic Adrenocortical Carcinoma

Author(s):

Lindsey Addington*, Hagman Thomas, Hawk, Nicole CMA and Pablo Bedano (USA)

Adrenocortical carcinoma (ACC) is a rare cancer with limited effective treatment options and poor prognosis. ACC incidence is 1 to 2 cases per million making randomized clinical trials difficult to conduct. The current standard first line treatment for metastatic ACC showing tumor response and improved progression free survival (PFS) is etoposide-doxorubicin-cisplatin (EDP) plus mitotane. Multiple efforts to find a targeted treatment for ACC have not shown impressive responses. Immunotherapy agents such as checkpoint inhibitors programmed cell death – 1 receptor (PD-1) and programmed cell deathligand 1 have shown significant responses in multiple malignancies including melanoma, non-small-cell-lung cancer, Hodgkin’s lymphoma to name a few. We present a case of a female patie... view moreĀ»

Abstract HTML PDF



Social Media

GET THE APP